Litcius/Paper detail

Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Ang Li, Yun Ling, Zhigang Song, Xiaobo Cheng, Longfei Ding, Ren-Di Jiang, Weihui Fu, Yan Liu, Huiliang Hu, Songhua Yuan, Jian Chen, Cuisong Zhu, Jun Fan, Jing Wang, Yanling Jin, Miaomiao Zhang, Lingyan Zhu, Peng Sun, Linxia Zhang, Ran Qin, Wei Zhang, Chenli Qiu, Yinzhong Shen, Lin Zhang, Zhengli Shi, Chen Zhao, Tongyu Zhu, Hongzhou Lu, Xiaoyan Zhang, Jianqing Xu

2020The Journal of Infectious Diseases27 citationsDOIOpen Access PDF

Abstract

BACKGROUND: The immune protective mechanisms during severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection remain to be deciphered for the development of an effective intervention approach. METHODS: We examined early responses of interleukin 37 (IL-37), a powerful anti-inflammatory cytokine, in 254 SARS-CoV-2-infected patients before any clinical intervention and determined its correlation with clinical prognosis. RESULTS: Our results demonstrated that SARS-CoV-2 infection causes elevation of plasma IL-37. Higher early IL-37 responses were correlated with earlier viral RNA negative conversion, chest computed tomographic improvement, and cough relief, consequently resulted in earlier hospital discharge. Further assays showed that higher IL-37 was associated with lower interleukin 6 and interleukin 8 (IL-8) and higher interferon α responses and facilitated biochemical homeostasis. Low IL-37 responses predicted severe clinical prognosis in combination with IL-8 and C-reactive protein. In addition, we observed that IL-37 administration was able to attenuate lung inflammation and alleviate respiratory tissue damage in human angiotensin-converting enzyme 2-transgenic mice infected with SARS-CoV-2. CONCLUSIONS: Overall, we found that IL-37 plays a protective role by antagonizing inflammatory responses while retaining type I interferon, thereby maintaining the functionalities of vital organs. IL-37, IL-8, and C-reactive protein might be formulated as a precise prediction model for screening severe clinical cases and have good value in clinical practice.

Topics & Concepts

MedicineImmunologyInflammationCytokineRespiratory systemImmune systemInterleukinCoronavirusInterleukin 10InterferonInternal medicineCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesPsoriasis: Treatment and PathogenesisLong-Term Effects of COVID-19